South Korea Ascites Market

ID: MRFR/HC/54587-HCR 200 Pages Satyendra Maurya Last Updated: September 17, 2026
South Korea Ascites Market Research Report: By Type (Transudative Ascites, Exudate Ascites), By Diagnosis (Ultrasound, CT Scan, Laparoscopy, Angiography), By Treatment (Surgeries) andBy End User (Hospitals & Clinics, Ambulatory Surgical Center, Diagnostic Centers)- Forecast to 2035
South Korea Ascites Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.44%
2018 Market Size$ 25.8 Million
2024 Market Size$ 27.46 Million
2035 Market Size$ 54.56 Million
Key Players
Samsung Biologics
Celltrion
Hanmi Pharmaceutical
LG Chem
SK Biopharmaceuticals
Daewoong Pharmaceutical
Opportunities
  • Aging Population
  • Rising Awareness of Liver Health
  • Increasing Healthcare Expenditure
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 South Korea Ascites Market, BY Application (USD Million)
      1. 4.1.1 Diagnostic
      2. 4.1.2 Therapeutic
      3. 4.1.3 Prognostic
      4. 4.1.4 Research
    2. 4.2 South Korea Ascites Market, BY Type of Ascites (USD Million)
      1. 4.2.1 Transudative
      2. 4.2.2 Exudative
      3. 4.2.3 Malignant
      4. 4.2.4 Cirrhotic
    3. 4.3 South Korea Ascites Market, BY Treatment Method (USD Million)
      1. 4.3.1 Paracentesis
      2. 4.3.2 Diuretics
      3. 4.3.3 Surgical Intervention
      4. 4.3.4 Transplantation
    4. 4.4 South Korea Ascites Market, BY Patient Demographics (USD Million)
      1. 4.4.1 Age Group
      2. 4.4.2 Gender
      3. 4.4.3 Underlying Conditions
      4. 4.4.4 Socioeconomic Status
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the South Korea Ascites Market
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the South Korea Ascites Market
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Samsung Biologics (KR)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Celltrion (KR)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Hanmi Pharmaceutical (KR)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 LG Chem (KR)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 SK Biopharmaceuticals (KR)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Daewoong Pharmaceutical (KR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Korea United Pharm (KR)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Medytox (KR)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    3. 6.3 SOUTH KOREA MARKET ANALYSIS BY TYPE OF ASCITES
    4. 6.4 SOUTH KOREA MARKET ANALYSIS BY TREATMENT METHOD
    5. 6.5 SOUTH KOREA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    6. 6.6 KEY BUYING CRITERIA OF SOUTH KOREA ASCITES MARKET
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF SOUTH KOREA ASCITES MARKET
    9. 6.9 DRIVERS IMPACT ANALYSIS: SOUTH KOREA ASCITES MARKET
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: SOUTH KOREA ASCITES MARKET
    11. 6.11 SUPPLY / VALUE CHAIN: SOUTH KOREA ASCITES MARKET
    12. 6.12 SOUTH KOREA ASCITES MARKET, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 SOUTH KOREA ASCITES MARKET, BY APPLICATION, 2024 TO 2035 (USD Million)
    14. 6.14 SOUTH KOREA ASCITES MARKET, BY TYPE OF ASCITES, 2024 (% SHARE)
    15. 6.15 SOUTH KOREA ASCITES MARKET, BY TYPE OF ASCITES, 2024 TO 2035 (USD Million)
    16. 6.16 SOUTH KOREA ASCITES MARKET, BY TREATMENT METHOD, 2024 (% SHARE)
    17. 6.17 SOUTH KOREA ASCITES MARKET, BY TREATMENT METHOD, 2024 TO 2035 (USD Million)
    18. 6.18 SOUTH KOREA ASCITES MARKET, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
    19. 6.19 SOUTH KOREA ASCITES MARKET, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
      2. 7.2.2 BY TYPE OF ASCITES, 2026-2035 (USD Million)
      3. 7.2.3 BY TREATMENT METHOD, 2026-2035 (USD Million)
      4. 7.2.4 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South Korea Ascites Market Segmentation

South Korea Ascites Market By Application (USD Million, 2022-2035)

  • Diagnostic
  • Therapeutic
  • Prognostic
  • Research

South Korea Ascites Market By Type of Ascites (USD Million, 2022-2035)

  • Transudative
  • Exudative
  • Malignant
  • Cirrhotic

South Korea Ascites Market By Treatment Method (USD Million, 2022-2035)

  • Paracentesis
  • Diuretics
  • Surgical Intervention
  • Transplantation

South Korea Ascites Market By Patient Demographics (USD Million, 2022-2035)

  • Age Group
  • Gender
  • Underlying Conditions
  • Socioeconomic Status
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.